Evidence map›Paper›PMID 41310336›Full record

ArticleNPJ breast cancer2025

Functional and clinical significance of the RNA m

Anna E Harris, Jennifer Lothion-Roy, Rachel L Thompson, Maria Haque, Corinne L Woodcock, Mansour A Alsaleem, Alexander Dean, Yousif Kariri, Michael S Toss, Lorraine J Gudas and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna E HarrisBiodiscovery Institute, University of Nottingham, Nottingham, UK. anna.harris@nottingham.ac.uk.
Jennifer Lothion-RoyBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Rachel L ThompsonBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Maria HaqueBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Corinne L WoodcockBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Mansour A AlsaleemBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Alexander DeanNottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Yousif KaririNottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Michael S TossNottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Lorraine J GudasDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Andrew R GreenBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Cinzia AllegrucciBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Melissa B DavisDepartment of Microbiology, Biochemistry and Immunology, and Institute of Translational Genomic Medicine, Morehouse School of Medicine, Atlanta, GA, USA.
Sheeba IrshadSchool of Cancer & Pharmaceutical Sciences, King's College London & Guys & St Thomas NHS Trust, London, UK.
Kyong-Hwa ParkCollege of Medicine, Korea University, Korea, Republic of Korea.
Srinivasan MadhusudanBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Rupert G FraySchool of Biosciences, University of Nottingham, Nottingham, UK.
Jennie N JeyapalanBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Catrin S RutlandBiodiscovery Institute, University of Nottingham, Nottingham, UK.
Emad A RakhaNottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Nigel P MonganBiodiscovery Institute, University of Nottingham, Nottingham, UK. nigel.mongan@nottingham.ac.uk.

Funding

The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune ResponseR01CA259396 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAVIS, MELISSA B, YATES, CLAYTON · 2021 to 2025
$2.4M
CANCER GRAND CHALLENGES 2024 SOCIETAL, ANCESTRY, MOLECULAR AND BIOLOGICAL ANALYSES OF INEQUALITIES (SAMBAI) Morehouse School of MedicineOT2CA297574 · NCI · MOREHOUSE SCHOOL OF MEDICINE · PI DAVIS, MELISSA B · 2024 to 2024
$614k
BBSRC BB/T008369/1; BB/I024291/1NCI NIH HHS OT2 CA297574NCI NIH HHS R01 CA259396NIMHD NIH HHS L60 MD011128philanthropic donation 36565532
6 · The paper itself

Abstract

The RNA modification N

Identifiers

PMID41310336
PMCPMC12722736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.